Travere Therapeutics Inc (TVTX)

04:19 AM

Capital Fund Management S.A. Acquires Shares of 101,406 Travere Therapeutics, Inc. $TVTX - MarketBeat

04:19 AM

Dec 04, 2025

Travere Therapeutics (NASDAQ:TVTX) CFO Christopher Cline Sells 20,000 Shares - MarketBeat

Dec 04, 2025

Dec 04, 2025

Panagora Asset Management Inc. Buys 96,062 Shares of Travere Therapeutics, Inc. $TVTX - MarketBeat

Dec 04, 2025

Dec 03, 2025

Travere Therapeutics CFO Sells 20,000 Shares - TradingView

Dec 03, 2025

Dec 03, 2025

Loomis Sayles & Co. L P Trims Position in Travere Therapeutics, Inc. $TVTX - MarketBeat

Dec 03, 2025

Dec 03, 2025

Travere Therapeutics (NASDAQ:TVTX) Is Carrying A Fair Bit Of Debt - 富途牛牛

Dec 03, 2025

Dec 03, 2025

Legal & General Group Plc Boosts Stake in Travere Therapeutics, Inc. $TVTX - MarketBeat

Dec 03, 2025

Dec 02, 2025

Travere Therapeutics, Inc. (TVTX) Investigation: Bronstein, Gewir - The National Law Review

Dec 02, 2025

Dec 02, 2025

Travere Therapeutics (TVTX) Stock Analysis Report | Ratings, Financials & Performance - Benzinga

Dec 02, 2025

Dec 01, 2025

Evercore Healthcare Conference - MarketScreener

Dec 01, 2025

Nov 30, 2025

The Insider Report: The Dip Was Bought Before the Holidays - Benzinga

Nov 30, 2025

Nov 29, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review

Nov 29, 2025

Nov 29, 2025

Is Travere Therapeutics Inc. stock a contrarian buyJuly 2025 Fed Impact & Verified Entry Point Signals - BỘ NỘI VỤ

Nov 29, 2025

Nov 29, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Travere Thera - The National Law Review

Nov 29, 2025

Nov 29, 2025

Travere Therapeutics, Inc. 2025 Q3ResultsEarnings Call Presentation (NASDAQ:TVTX) 2025-11-29 - Seeking Alpha

Nov 29, 2025

Nov 28, 2025

Travere Therapeutics stock hits 52-week high at 37.12 USD By Investing.com - Investing.com Nigeria

Nov 28, 2025

Nov 28, 2025

Travere Therapeutics stock hits 52-week high at 37.12 USD - Investing.com

Nov 28, 2025

Nov 28, 2025

TVTX: HC Wainwright Reiterates Buy Rating and Maintains Price Ta - GuruFocus

Nov 28, 2025

Nov 28, 2025

HC Wainwright & Co. Reiterates Travere Therapeutics (TVTX) Buy Recommendation - Nasdaq

Nov 28, 2025

Nov 28, 2025

Travere Therapeutics Delivers Growth As FILSPARI Drives Profits - Finimize

Nov 28, 2025

Nov 27, 2025

A Look at Travere Therapeutics’s Valuation Following FDA Updates Boosting FILSPARI’s Accessibility and Growth Prospects - Sahm

Nov 27, 2025

Nov 27, 2025

How Travere Therapeutics Inc. stock reacts to bond yieldsWeekly Stock Recap & AI Driven Stock Movement Reports - BỘ NỘI VỤ

Nov 27, 2025

Nov 26, 2025

How Travere Therapeutics Inc. stock trades during market volatilityWeekly Stock Analysis & Safe Entry Trade Reports - BỘ NỘI VỤ

Nov 26, 2025

Nov 26, 2025

Travere Therapeutics: Thriving Kidney Franchise Set To Soar On January PDUFA (TVTX) - Seeking Alpha

Nov 26, 2025

Nov 21, 2025

American Kidney Fund Hosts Third Patient Access Initiative Summit to Address Barriers to Kidney Care and Propose Innovative Solutions - GlobeNewswire Inc.

Nov 21, 2025

Nov 21, 2025

How institutional buying supports Travere Therapeutics Inc. stockMarket Trend Summary & Daily Profit Maximizing Trade Tips - newser.com

Nov 21, 2025

Nov 21, 2025

Will Travere Therapeutics Inc. stock maintain dividend yieldWeekly Earnings Recap & Real-Time Chart Breakout Alerts - newser.com

Nov 21, 2025

Nov 21, 2025

Is Travere Therapeutics Inc. stock trading at a premium valuationWeekly Loss Report & AI Driven Price Predictions - newser.com

Nov 21, 2025

Nov 20, 2025

Is Travere Therapeutics Inc. stock in correction or buying zoneJuly 2025 Fed Impact & Real-Time Chart Pattern Alerts - newser.com

Nov 20, 2025

Nov 20, 2025

(TVTX) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com

Nov 20, 2025

Nov 19, 2025

What makes Travere Therapeutics Inc. stock attractive to growth funds2025 Top Decliners & Expert Approved Trade Ideas - newser.com

Nov 19, 2025

Nov 19, 2025

What indicators show strength in Travere Therapeutics Inc.July 2025 Price Swings & AI Powered Market Trend Analysis - newser.com

Nov 19, 2025

Nov 19, 2025

What momentum shifts mean for Travere Therapeutics Inc.2025 Technical Overview & Safe Capital Growth Stock Tips - newser.com

Nov 19, 2025

Nov 19, 2025

Can Travere Therapeutics Inc. stock deliver strong Q4 earningsPortfolio Risk Report & Weekly Watchlist of Top Performers - newser.com

Nov 19, 2025

Nov 19, 2025

How Travere Therapeutics Inc. stock compares to industry benchmarksQuarterly Performance Summary & Weekly Breakout Stock Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

Will Travere Therapeutics Inc. stock outperform international peersTrade Risk Report & Free Expert Approved Momentum Trade Ideas - newser.com

Nov 19, 2025

Nov 19, 2025

Will Positive Phase 3 FILSPARI Data in FSGS Redefine Travere Therapeutics' (TVTX) Position in Rare Kidney Disease? - sahmcapital.com

Nov 19, 2025

Nov 19, 2025

Real time scanner hits for Travere Therapeutics Inc. explainedMarket Volume Report & Weekly High Return Stock Forecasts - newser.com

Nov 19, 2025

Nov 18, 2025

Why This Fund Trimmed a $161 Million Travere Position After a 100% Rally - AOL.com

Nov 18, 2025

Nov 18, 2025

Travere Therapeutics stock hits 52-week high at 36.81 USD By Investing.com - Investing.com Canada

Nov 18, 2025